Sanders Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-12,249,376
Closed -$723M 45
2021
Q4
$723M Sell
12,249,376
-6,534,246
-35% -$324M 1.48% 21
2021
Q3
$808M Sell
18,783,622
-14,691,363
-44% -$651M 1.83% 19
2021
Q2
$1.31B Buy
33,474,985
+1,272,869
+4% +$49.5M 2.97% 15
2021
Q1
$1.17B Buy
32,202,116
+254,300
+0.8% +$9.03M 2.81% 16
2020
Q4
$1.18B Buy
31,947,816
+1,491,455
+5% +$54.7M 3.1% 13
2020
Q3
$1.06B Buy
30,456,361
+647,121
+2% +$22.7M 3.64% 10
2020
Q2
$925M Buy
29,809,240
+1,421,859
+5% +$48.3M 3.46% 10
2020
Q1
$879M Buy
28,387,381
+460,475
+2% +$15.7M 4.12% 9
2019
Q4
$1.04B Buy
27,926,906
+3,070,825
+12% +$109M 3.67% 9
2019
Q3
$847M Buy
24,856,081
+5,094,551
+26% +$185M 3.8% 8
2019
Q2
$812M Buy
19,761,530
+639,461
+3% +$25.4M 3.73% 10
2019
Q1
$771M Buy
19,122,069
+893,265
+5% +$35.8M 3.7% 8
2018
Q4
$755M Sell
18,228,804
-1,142,009
-6% -$47.4M 4.2% 5
2018
Q3
$810M Sell
19,370,813
-1,802,442
-9% -$69.4M 4.08% 8
2018
Q2
$729M Buy
21,173,255
+22,977
+0.1% +$785K 3.91% 8
2018
Q1
$712M Sell
21,150,278
-31,725
-0.1% -$1.09M 3.95% 8
2017
Q4
$728M Buy
21,182,003
+2,717,317
+15% +$92.7M 3.96% 10
2017
Q3
$625M Buy
18,464,686
+617,223
+3% +$19.8M 3.77% 10
2017
Q2
$569M Buy
17,847,463
+1,732,814
+11% +$54.6M 3.66% 13
2017
Q1
$538M Buy
16,114,649
+300,706
+2% +$9.48M 3.57% 13
2016
Q4
$487M Buy
15,813,943
+991,295
+7% +$30.3M 3.47% 14
2016
Q3
$476M Sell
14,822,648
-213,962
-1% -$7.15M 3.76% 12
2016
Q2
$502M Buy
15,036,610
+15,625
+0.1% +$499K 4.17% 10
2016
Q1
$422M Buy
15,020,985
+4,198,829
+39% +$120M 3.65% 11
2015
Q4
$331M Buy
+10,822,156
New +$340M 3.04% 14

Other funds holding PFE